Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer. Issue 8 (6th February 2018)
- Record Type:
- Journal Article
- Title:
- Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer. Issue 8 (6th February 2018)
- Main Title:
- Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer
- Authors:
- Roche, Ansley M.
Fedewa, Stacey A.
Shi, Lucy L.
Chen, Amy Y. - Abstract:
- Abstract : BACKGROUND: Anaplastic thyroid cancer (ATC) is the rarest type of thyroid cancer and has the lowest overall survival. To the authors' knowledge, the impact of socioeconomic status and race/ethnicity has not yet been described. METHODS: Data regarding 719 patients diagnosed with their first primary malignant ATC from January 1, 1998 to December 31, 2011 in the Surveillance, Epidemiology, and End Results program registries were examined. Differences in receipt of thyroidectomy, radiotherapy, and lymph node examination were examined by race/ethnicity. Survival also was examined by race/ethnicity. RESULTS: Nearly 70% of patients were non‐Hispanic white, and 55.4% of patients received treatment. Tumor size ( P = .13), lymph node involvement ( P = .60), and residence in high poverty neighborhoods ( P = .08) did not vary by race/ethnicity. Nonwhite patients were more likely to receive no treatment (adjusted odds ratio, 0.29; 95% confidence interval [95% CI], 0.16‐0.54). When receipt of radiotherapy was adjusted for, nonwhite patients had a higher risk of overall death (adjusted hazards ratio [aHR], 1.24; 95% CI, 1.01‐1.54), although not disease‐specific death (aHR, 1.14; 95% CI, 0.92‐1.42). Patients living in areas of high poverty had lower overall survival (aHR, 1.54; 95% CI, 1.09‐2.18) and disease‐specific survival (aHR, 1.68; 95% CI, 1.19‐2.36). CONCLUSIONS: In this population‐based study of patients with ATC, nonwhite patients were found to be less likely toAbstract : BACKGROUND: Anaplastic thyroid cancer (ATC) is the rarest type of thyroid cancer and has the lowest overall survival. To the authors' knowledge, the impact of socioeconomic status and race/ethnicity has not yet been described. METHODS: Data regarding 719 patients diagnosed with their first primary malignant ATC from January 1, 1998 to December 31, 2011 in the Surveillance, Epidemiology, and End Results program registries were examined. Differences in receipt of thyroidectomy, radiotherapy, and lymph node examination were examined by race/ethnicity. Survival also was examined by race/ethnicity. RESULTS: Nearly 70% of patients were non‐Hispanic white, and 55.4% of patients received treatment. Tumor size ( P = .13), lymph node involvement ( P = .60), and residence in high poverty neighborhoods ( P = .08) did not vary by race/ethnicity. Nonwhite patients were more likely to receive no treatment (adjusted odds ratio, 0.29; 95% confidence interval [95% CI], 0.16‐0.54). When receipt of radiotherapy was adjusted for, nonwhite patients had a higher risk of overall death (adjusted hazards ratio [aHR], 1.24; 95% CI, 1.01‐1.54), although not disease‐specific death (aHR, 1.14; 95% CI, 0.92‐1.42). Patients living in areas of high poverty had lower overall survival (aHR, 1.54; 95% CI, 1.09‐2.18) and disease‐specific survival (aHR, 1.68; 95% CI, 1.19‐2.36). CONCLUSIONS: In this population‐based study of patients with ATC, nonwhite patients were found to be less likely to receive treatment. Furthermore, nonwhite patients had poorer overall survival, and patients living in areas of high poverty had both worse overall and disease‐specific survival. Racial/ethnic and socioeconomic disparities appear to exist in the treatment and survival of patients with ATC. Cancer 2018;124:1780‐90 . © 2018 American Cancer Society Abstract : In this population‐based cohort study of patients diagnosed with anaplastic thyroid cancer, the authors demonstrate that nonclinical factors, specifically nonwhite race, high poverty level, and lack of a high school education, are independently associated with treatment and overall survival, but not cause‐specific survival, tumor size, or lymph node involvement. Recognizing treatment and survival differences in patients with anaplastic thyroid cancer may contribute to improvements in access to care in these patients as well as more unbiased discussions of treatment in patients of all races/ethnicities, educational levels, and socioeconomic status. … (more)
- Is Part Of:
- Cancer. Volume 124:Issue 8(2018)
- Journal:
- Cancer
- Issue:
- Volume 124:Issue 8(2018)
- Issue Display:
- Volume 124, Issue 8 (2018)
- Year:
- 2018
- Volume:
- 124
- Issue:
- 8
- Issue Sort Value:
- 2018-0124-0008-0000
- Page Start:
- 1780
- Page End:
- 1790
- Publication Date:
- 2018-02-06
- Subjects:
- anaplastic -- bias -- continental population groups -- ethnic groups -- health care disparities -- poverty -- radiotherapy -- thyroid carcinoma -- thyroid neoplasms
Cancer -- Periodicals
Cancer -- Cytopathology -- Periodicals
616.99405 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cncr.31252 ↗
- Languages:
- English
- ISSNs:
- 0008-543X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.450000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6370.xml